Bioworld Financial Watch articles from September 2004

Bioworld Financial Watch archives from September 2004

Chiron, Gilead marching forward: viral wars fought on two fronts.
September 6, 2004... The Chinese ideogram for "crisis" also means "opportunity" and, although the ancient makers of symbolic language probably didn't consider avian influenza, the coincidence has an eerie resonance. In May, Chiron Corp. gained a government...

10 biggest U.S. gainers for the week.
September 6, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Zonagen 27.30 MGI Pharma 5.49 Avanir 27.27 Epix Medical 2.52 Acadia 26.06 Pharmion 1.90 Ortec Int'l 25.83...

10 biggest U.S. losers for the week.
September 6, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Biopure -24.59 ImClone Sys -2.47 Valentis -15.88 Flamel Tech -1.58 Alliance -13.33 United Thera -1.22 NeoRx...

Public financing of biotechnology: August 2004.
September 6, 2004... Public Financing Of Biotechnology: August 2004 I. COMMENCED TRADING IN AUGUST Company Date Date Shares/ Price (Symbol) (#) Filed Comm. Units (M) INITIAL OFFERINGS New River 5/6/04...

Other financings of public biotechnology companies: August 2004.
September 6, 2004... Other Financings Of Public Biotechnology Companies: August 2004 TOTAL: $334.89M Number Of Shares, Company Type Of Units Amount...

Venture capital and corporate investments in biotechnology companies: August 2004.
September 6, 2004... I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $466.46M Company Location Date Amt. (M) Aerovance Menlo Park, Calif. 8/23/04 $32 Inc. Ambit San Diego ...

BioWorld stock report for public biotechnology companies.
September 6, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 8/27 9/3 WK YTD (000) Aastrom Biosci ASTM 0.82 ...

Vivus Phase III with Alprostadil aiming at 'Huge' FSAD market.
September 13, 2004... For reasons that might be as much socio-economic as medical, female sexual arousal disorder (FSAD) has been overlooked in favor of the lucrative market for erectile dysfunction therapies such as the pioneering phosphodiesterase type-5 inhibitor...

10 biggest U.S. gainers for the week.
September 13, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) CytRx 33.02 Valentis 27.91 Northwest BioThera 25.00 Third Wave Tech 22.86 Cygnus 20.00 Cepheid 18.13 Axonyx ...

10 biggest U.S. losers for the week.
September 13, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Imcor -31.25 Biopure -15.22 MacroChem -14.29 AVI BioPharma -13.51 Adolor -11.80 Immunomedics -11.64 SciClone -11.54...

Clinical trials update: August 2004.
September 13, 2004... Clinical Trials Update: August 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Advitech Inc. XP-828L Oral bioactive complex (Canada; TSE:AVI) derived...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: August 2004.
September 13, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Biogen Idec Antegren Humanized...

FDA submissions, approvals and other actions: August 2004.
September 13, 2004... FDA Submissions, Approvals And Other Actions: August 2004 Company* Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories ...

BioWorld stock report for public biotechnology companies.
September 13, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 9/3 9/10 WK YTD (000) Aastrom Biosci ASTM 0.94 ...

Celgene's Revlimid looks strong in bid to grab MDS market share.(Company Ripe for Takeover?)
September 20, 2004... With profitability reached last year, a rise in its stock price of more than 25 percent since the start of 2004, the FDA reviewing Thalomid for blood cancer and a 2-for-1 stock split due for shareholders next month, Celgene Corp. is sitting...

10 biggest U.S. gainers for the week.
September 20, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Avax Technol 40.00 Imcor 36.36 EntreMed 20.81 Deltagen 20.00 Sequenom 18.95 Idenix 18.52 Repligen 18.18 Access Pharma...

10 biggest U.S. losers for the week.
September 20, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Northwest BioThera -20.00 Flamel Tech -18.44 Xcyte Therapies -16.10 Corixa -16.03 Ortec Int'l -15.79 Genetronics -14.44...

Biotechnology company deals with other biotechnology companies: collaborations, agreements, equity participation, June 24-Sept. 16, 2004.
September 20, 2004... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, June 24-Sept. 16, 2004 Company * Company * Type/Product Area (Country; (Country;...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, June 24-Sept. 16, 2004.
September 20, 2004... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, June 24-Sept. 16, 2004 Company * Company Type/Product Area (Country; Symbol) CombiMatrix ...

Manufacturing, marketing and distribution agreements between biotech companies: June 24-Sept. 16, 2004.
September 20, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: June 24-Sept. 16, 2004 Company * Company * (Country; (Country; Symbol) Symbol) Albany ...

Biotech--biotech collaborations: modified and terminated agreements, June 24-Sept. 16, 2004.
September 20, 2004... Biotech--Biotech Collaborations: Modified And Terminated Agreements, June 24-Sept. 16, 2004 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; ...

BioWorld stock report for public biotechnology companies.
September 20, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/10 9/17 Aastrom Biosci ASTM 0.88 0.91...

Tarceva ushering OSI toward 'critical juncture' in evolution.
September 27, 2004... Tarceva, the eye-opening cancer drug with a new drug application pending, typically is regarded as another feather in the cap of Genentech Inc., whose headgear already is festooned with plumage. Sure enough, the compound--which last week...

10 biggest U.S. gainers for the week.
September 27, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Oxis Int'l 59.52 Atherogenics 30.33 Inhibitex 29.49 MannKind 27.82 Cytokinetics 27.10 Northwest...

10 biggest U.S. losers for the week.
September 27, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Maxim Pharma -52.86 Miravant -32.22 Anadys -20.71 Valentis -19.05 Dendreon ...

Biotech mergers and acquisitions: May 27-Sept. 22, 2004 #.
September 27, 2004... Biotech Mergers And Acquisitions: May 27-Sept. 22, 2004 # I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country;...

BioWorld stock report for public biotechnology companies.
September 27, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 09/17 09/24 Aastrom Biosci ASTM 0.91 0.92 Abgenix ...